The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
STAT1 and STAT3 in tumorigenesis: A matter of balance
Open accessAbstract
The transcription factors STAT1 and STAT3 appear to play opposite roles in tumorigenesis. While STAT3 promotes cell survival/proliferation, motility and immune tolerance and is considered as an oncogene, STAT1 mostly triggers anti-proliferative and pro-apoptotic responses while enhancing anti-tumor immunity. Despite being activated downstream of common cytokine and growth factor receptors, their activation is reciprocally regulated and perturbation in their balanced expression or phosphorylation levels may re-direct cytokine/growth factor signals from proliferative to apoptotic, or from inflammatory to anti-inflammatory. Here we review the functional canonical and non-canonical effects of STAT1 and STAT3 activation in tumorigenesis and their potential cross-regulation mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Opposite Regulation of Myc and p21 Transcription by STAT3 Proteins
Barré, B., Avril, S., & Coqueret, O. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210422200 · Cited by 110
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
Uyttenhove, C., Pilotte, L., Théate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T., & Van den Eynde, B. J. (2003) · Nature Medicine · doi:10.1038/nm934 · Cited by 2,305
Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155
Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
HEINRICH, P. C., BEHRMANN, I., MÜLLER-NEWEN, G., SCHAPER, F., & GRAEVE, L. (1998) · Biochemical Journal · doi:10.1042/bj3340297 · Cited by 2,130
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
Yu, H., Kortylewski, M., & Pardoll, D. (2007) · Nature Reviews Immunology · doi:10.1038/nri1995 · Cited by 1,804
IFNα activates dormant haematopoietic stem cells in vivo
Essers, M. A. G., Offner, S., Blanco-Bose, W. E., Waibler, Z., Kalinke, U., Duchosal, M. A., & Trumpp, A. (2009) · Nature · doi:10.1038/nature07815 · Cited by 1,368
JAK-STAT Signaling: From Interferons to Cytokines
Schindler, C., Levy, D. E., & Decker, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r700016200 · Cited by 1,258
Christiansen, J. J., & Rajasekaran, A. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0410 · Cited by 1,046
Function of Mitochondrial Stat3 in Cellular Respiration
Wegrzyn, J., Potla, R., Chwae, Y.-J., Sepuri, N. B. V., Zhang, Q., Koeck, T., Derecka, M., Szczepanek, K., Szelag, M., Gornicka, A., et al. (2009) · Science · doi:10.1126/science.1164551 · Cited by 1,014
Chalmin, F., Ladoire, S., Mignot, G., Vincent, J., Bruchard, M., Remy-Martin, J.-P., Boireau, W., Rouleau, A., Simon, B., Lanneau, D., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40483 · Cited by 998
Bollrath, J., Phesse, T. J., von Burstin, V. A., Putoczki, T., Bennecke, M., Bateman, T., Nebelsiek, T., Lundgren-May, T., Canli, Ö., Schwitalla, S., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.002 · Cited by 946
A Five-Gene Signature and Clinical Outcome in Non–Small-Cell Lung Cancer
Chen, H.-Y., Yu, S.-L., Chen, C.-H., Chang, G.-C., Chen, C.-Y., Yuan, A., Cheng, C.-L., Wang, C.-H., Terng, H.-J., Kao, S.-F., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa060096 · Cited by 935
Marotta, L. L. C., Almendro, V., Marusyk, A., Shipitsin, M., Schemme, J., Walker, S. R., Bloushtain-Qimron, N., Kim, J. J., Choudhury, S. A., Maruyama, R., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44745 · Cited by 911
Lesina, M., Kurkowski, M. U., Ludes, K., Rose-John, S., Treiber, M., Klöppel, G., Yoshimura, A., Reindl, W., Sipos, B., Akira, S., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.03.009 · Cited by 862
Sansone, P., Storci, G., Tavolari, S., Guarnieri, T., Giovannini, C., Taffurelli, M., Ceccarelli, C., Santini, D., Paterini, P., Marcu, K. B., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32533 · Cited by 779
Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells
Sullivan, N. J., Sasser, A. K., Axel, A. E., Vesuna, F., Raman, V, Ramirez, N., Oberyszyn, T. M., & Hall, B. M. (2009) · Oncogene · doi:10.1038/onc.2009.180 · Cited by 757
Mitochondrial STAT3 Supports Ras-Dependent Oncogenic Transformation
Gough, D. J., Corlett, A., Schlessinger, K., Wegrzyn, J., Larner, A. C., & Levy, D. E. (2009) · Science · doi:10.1126/science.1171721 · Cited by 716
Zhou, J., Wulfkuhle, J., Zhang, H., Gu, P., Yang, Y., Deng, J., Margolick, J. B., Liotta, L. A., Petricoin, E., & Zhang, Y. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702596104 · Cited by 698
Iliopoulos, D., Hirsch, H. A., Wang, G., & Struhl, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018898108 · Cited by 643
Stat3 Activation Is Required for Cellular Transformation by v- src
Bromberg, J. F., Horvath, C. M., Besser, D., Lathem, W. W., & Darnell, J. E. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2553 · Cited by 614
Inflammation and Cancer: IL-6 and STAT3 Complete the Link
Bromberg, J., & Wang, T. C. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.009 · Cited by 542
Stat3 and MMP7 Contribute to Pancreatic Ductal Adenocarcinoma Initiation and Progression
Fukuda, A., Wang, S. C., Morris, J. P., Folias, A. E., Liou, A., Kim, G. E., Akira, S., Boucher, K. M., Firpo, M. A., Mulvihill, S. J., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.03.002 · Cited by 521
Activation of the STAT Signaling Pathway Can Cause Expression of Caspase 1 and Apoptosis
Chin, Y. E., Kitagawa, M., Kuida, K., Flavell, R. A., & Fu, X.-Y. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5328 · Cited by 521
STAT3 Is Required for Proliferation and Maintenance of Multipotency in Glioblastoma Stem Cells
Sherry, M. M., Reeves, A., Wu, J. K., & Cochran, B. H. (2009) · Stem Cells · doi:10.1002/stem.185 · Cited by 478
Regulation of the IL-23 and IL-12 Balance by Stat3 Signaling in the Tumor Microenvironment
Kortylewski, M., Xin, H., Kujawski, M., Lee, H., Liu, Y., Harris, T., Drake, C., Pardoll, D., & Yu, H. (2009) · Cancer Cell · doi:10.1016/j.ccr.2008.12.018 · Cited by 474
STAT1 Signaling Regulates Tumor-Associated Macrophage-Mediated T Cell Deletion
Kusmartsev, S., & Gabrilovich, D. I. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4880 · Cited by 445
NF-κB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration
Mauro, C., Leow, S. C., Anso, E., Rocha, S., Thotakura, A. K., Tornatore, L., Moretti, M., De Smaele, E., Beg, A. A., Tergaonkar, V., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2324 · Cited by 394
Zinc transporter LIVI controls epithelial-mesenchymal transition in zebrafish gastrula organizer
Yamashita, S., Miyagi, C., Fukada, T., Kagara, N., Che, Y.-S., & Hirano, T. (2004) · Nature · doi:10.1038/nature02545 · Cited by 351
Stat3 controls lysosomal-mediated cell death in vivo
Kreuzaler, P. A., Staniszewska, A. D., Li, W., Omidvar, N., Kedjouar, B., Turkson, J., Poli, V., Flavell, R. A., Clarkson, R. W. E., & Watson, C. J. (2011) · Nature Cell Biology · doi:10.1038/ncb2171 · Cited by 312
Self-citationTwist Is Transcriptionally Induced by Activation of STAT3 and Mediates STAT3 Oncogenic Function
Cheng, G. Z., Zhang, W., Sun, M., Wang, Q., Coppola, D., Mansour, M., Xu, L., Costanzo, C., Cheng, J. Q., & Wang, L.-H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707429200 · Cited by 285
Stat3 regulates microtubules by antagonizing the depolymerization activity of stathmin
Ng, D. C. H., Lin, B. H., Lim, C. P., Huang, G., Zhang, T., Poli, V., & Cao, X. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200503021 · Cited by 278
Self-citationMutational switch of an IL-6 response to an interferon-γ-like response
Costa-Pereira, A. P., Tininini, S., Strobl, B., Alonzi, T., Schlaak, J. F., Is'harc, H., Gesualdo, I., Newman, S. J., Kerr, I. M., & Poli, V. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122236099 · Cited by 264
Self-citationActivated Signal Transducer and Activator of Transcription (STAT) 3
Silver, D. L., Naora, H., Liu, J., Cheng, W., & Montell, D. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3959 · Cited by 252
A STAT3-mediated metabolic switch is involved in tumour transformation and STAT3 addiction
Demaria, M., Giorgi, C., Lebiedzinska, M., Esposito, G., D'Angeli, L., Bartoli, A., Gough, D. J., Turkson, J., Levy, D. E., Watson, C. J., et al. (2010) · Aging · doi:10.18632/aging.100232 · Cited by 250
Self-citationUps and downs: The STAT1:STAT3 seesaw of Interferon and gp130 receptor signalling
Regis, G., Pensa, S., Boselli, D., Novelli, F., & Poli, V. (2008) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2008.06.004 · Cited by 236
Self-citationThe STAT3 isoforms α and β have unique and specific functions
Maritano, D., Sugrue, M. L., Tininini, S., Dewilde, S., Strobl, B., Fu, X., Murray-Tait, V., Chiarle, R., & Poli, V. (2004) · Nature Immunology · doi:10.1038/ni1052 · Cited by 234
Self-citationSystematic review of the association between circulating interleukin-6 (IL-6) and cancer
Heikkilä, K., Ebrahim, S., & Lawlor, D. A. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.02.047 · Cited by 232
Widschwendter, A., Geymayer, S., Welte, T., Daxenbichler, G., Marth, C., & Doppler, W. (2002) · PubMed · Cited by 218
STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas
Chan, S. R., Vermi, W., Luo, J., Lucini, L., Rickert, C., Fowler, A. M., Lonardi, S., Arthur, C., Young, L. J., Levy, D. E., et al. (2012) · Breast Cancer Research · doi:10.1186/bcr3100 · Cited by 193
HDAC4-Regulated STAT1 Activation Mediates Platinum Resistance in Ovarian Cancer
Stronach, E. A., Alfraidi, A., Rama, N., Datler, C., Studd, J. B., Agarwal, R., Guney, T. G., Gourley, C., Hennessy, B. T., Mills, G. B., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4111 · Cited by 176
Fantin, V. R., Loboda, A., Paweletz, C. P., Hendrickson, R. C., Pierce, J. W., Roth, J. A., Li, L., Gooden, F., Korenchuk, S., Hou, X. S., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6091 · Cited by 170
Simpson, J. A. D., Al-Attar, A., Watson, N. F. S., Scholefield, J. H., Ilyas, M., & Durrant, L. G. (2010) · Gut · doi:10.1136/gut.2009.194472 · Cited by 167
Stat3 Is a Negative Regulator of Intestinal Tumor Progression in ApcMin Mice
Musteanu, M., Blaas, L., Mair, M., Schlederer, M., Bilban, M., Tauber, S., Esterbauer, H., Mueller, M., Casanova, E., Kenner, L., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.11.049 · Cited by 166
Self-citationSTAT‐1: a novel regulator of apoptosis
Stephanou, A., & Latchman, D. S. (2003) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2003.00363.x · Cited by 165
STAT1 acts as a tumor promoter for leukemia development
Kovačic, B., Stoiber, D., Moriggl, R., Weisz, E., Ott, R. G., Kreibich, R., Levy, D. E., Beug, H., Freissmuth, M., & Sexl, V. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.05.025 · Cited by 155
Critchley-Thorne, R. J., Yan, N., Nacu, Ş., Weber, J. S., Holmes, S., & Lee, P. P. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040176 · Cited by 150
Barbieri, I., Pensa, S., Pannellini, T., Quaglino, E., Maritano, D., Demaria, M., Voster, A., Turkson, J., Cavallo, F., Watson, C. J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2840 · Cited by 148 · cited 8×
“The immediate early genes Fos and Egr1 become STAT1 transcriptional targets in the absence of STAT3.”
BackgroundInfluentialSelf-citationChen, Y., Chen, K.-H., Huang, P., Chen, Y., Chiou, G.-Y., Lo, W., Tseng, L., Hsu, H.-S., Chang, K., & Chiou, S. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0504 · Cited by 138
Greenwood, C., Metodieva, G., Al-Janabi, K., Lausen, B., Alldridge, L. C., Leng, L., Bucala, R., Fernández, N., & Metodiev, M. V. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.11.033 · Cited by 119
Lin, L., Fuchs, J. R., Li, C., Olson, V., Bekaii‐Saab, T., & Lin, J. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.10.112 · Cited by 117
Allione, A., Bernabei, P., Bosticardo, M., Ariotti, S., Forni, G., & Novelli, F. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.8.4182 · Cited by 112
Self-citationLeibowitz, M. S., Filho, P. A. A., Ferrone, S., & Ferris, R. L. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0961-7 · Cited by 106
Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer
Khodarev, N. N., Ahmad, R., Rajabi, H. N., Pitroda, S. P., Kufe, T., McClary, C., Joshi, M. D., MacDermed, D. M., Weichselbaum, R., & Kufe, D. W. (2009) · Oncogene · doi:10.1038/onc.2009.391 · Cited by 103
Allione, A., Bernabei, P., Bosticardo, M., Ariotti, S., Forni, G., & Novelli, F. (1999) · PubMed · Cited by 99
Self-citationÁlvaro, T., Lejeune, M., Camacho, F. I., Salvadó, M. T., Sánchez, L., García, J. F., López, C., Jaén, J., Bosch, R., Pons, L. E., et al. (2006) · PubMed · Cited by 93
Inhibition of Stat3 increases doxorubicin sensitivity in a human metastatic breast cancer cell line
Gariboldi, M. B., Ravizza, R., Molteni, R., Osella, D., Gabano, E., & Monti, E. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.08.019 · Cited by 90
Heuser, M., Sly, L. M., Argiropoulos, B., Kuchenbauer, F. C., Lai, C. K., Weng, A. P., Leung, M., Lin, G., Brookes, C., Fung, S., et al. (2009) · Blood · doi:10.1182/blood-2009-06-227603 · Cited by 87
Souissi, I., Najjar, I., Koon, L. A., Schischmanoff, P. O., Lesage, D., Coquil, S. L., Roger, C., Dusanter‐Fourt, I., Varin‐Blank, N., Cao, A., et al. (2011) · BMC Cell Biology · doi:10.1186/1471-2121-12-14 · Cited by 71
Lui, V. W. Y., Boehm, A. L., Koppikar, P., Leeman‐Neill, R. J., Johnson, D. E., Ogagan, M. J., Childs, E. E., Freilino, M. L., & Grandis, J. R. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.032284 · Cited by 67
Charpin, C., Secq, V., Giusiano, S., Carpentier, S., Andrac, L., Lavaut, M., Allasia, C., Bonnier, P., & Garcia, S. (2008) · International Journal of Cancer · doi:10.1002/ijc.24177 · Cited by 61
Raven, J. F., Williams, V., Wang, S., Tremblay, M. L., Muller, W. J., Durbin, J. E., & Koromilas, A. E. (2011) · Cell Cycle · doi:10.4161/cc.10.5.14956 · Cited by 59
Liddle, F. J., Alvarez, J. V., Poli, V., & Frank, D. A. (2006) · Biochemistry · doi:10.1021/bi0525674 · Cited by 55
Self-citationInterferons as a paradigm for cytokine signal transduction
Schindler, C., & Brutsaert, S. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050391 · Cited by 53
STAT1 and STAT3 in Tumorigenesis: Two Sides of the Same Coin?
Jr., R. H. B. (2009) · CRC Press eBooks · doi:10.1201/9781498713764-13 · Cited by 50
Regis, G., Icardi, L., Conti, L., Chiarle, R., Piva, R., Giovarelli, M., Poli, V, & Novelli, F. (2009) · Leukemia · doi:10.1038/leu.2009.139 · Cited by 47
Self-citationLee, H., Deng, J., Xin, H., Liu, Y., Pardoll, D., & Yu, H. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3304 · Cited by 44
The immediate early genes Fos and Egr1 become STAT1 transcriptional targets in the absence of STAT3
Schiavone, D., Avalle, L., Dewilde, S., & Poli, V. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.06.020 · Cited by 41
Self-citationSchultz, J., Koczan, D., Schmitz, U., Ibrahim, S. M., Pilch, D., Landsberg, J., & Kunz, M. (2010) · Clinical & Experimental Metastasis · doi:10.1007/s10585-010-9310-7 · Cited by 39
Li, L., & Shaw, P. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606940200 · Cited by 38
Ugarte-Berzal, E., Redondo-Muñóz, J., Eroles, P., del Cerro, M. H., Garcia-Marco, J. A., Terol, M. J., & Garcı́a-Pardo, A. (2009) · Blood · doi:10.1182/blood-2009-08-239426 · Cited by 34
STAT1 represses hypoxia-inducible factor-1-mediated transcription
Hiroi, M., Mori, K., Sakaeda, Y., Shimada, J., & Ohmori, Y. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.138 · Cited by 33
Fitzner, B., Brock, P., Nechutová, H., Glass, A. S., Karopka, T., Koczan, D., Thiesen, H., Sparmann, G. H., Emmrich, J., Liebe, S., et al. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.10.002 · Cited by 29
Simons, D. L., Lee, G., Kirkwood, J. M., & Lee, P. P. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-52 · Cited by 27
Sung (2009) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000196 · Cited by 19
Ilkovitch, D., Handel-Fernandez, M. E., Herbert, L. M., & Lopez, D. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5651 · Cited by 15
Cited by
Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer
Jones, S. A., & Jenkins, B. J. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0066-7 · Cited by 1,102
JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression
Owen, K. L., Brockwell, N. K., & Parker, B. S. (2019) · Cancers · doi:10.3390/cancers11122002 · Cited by 714
Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations
Milner, J. D., Vogel, T. P., Forbes, L., Ma, C. A., Stray-Pedersen, A., Niemela, J. E., Lyons, J. J., Engelhardt, K. R., Zhang, Y., Topcagic, N., et al. (2015) · Blood · doi:10.1182/blood-2014-09-602763 · Cited by 557
cGAS–STING drives the IL-6-dependent survival of chromosomally instable cancers
Hong, C., Schubert, M., Tijhuis, A. E., Requesens, M., Roorda, M., van den Brink, A., Ruiz, L. A., Bakker, P. L., van der Sluis, T., Pieters, W., et al. (2022) · Nature · doi:10.1038/s41586-022-04847-2 · Cited by 371
JAK/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens
Hu, Q., Bian, Q., Rong, D., Wang, L., Song, J., Huang, H.-S., Zeng, J., Mei, J., & Wang, P.-Y. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1110765 · Cited by 339
Metadata
- Authors
- Avalle, L., Pensa, S., Regis, G., Novelli, F., & Poli, V.
- Venue
- JAK-STAT
- Publisher
- Informa UK Limited
- Published
- 2012-04
- Volume
- 1
- Issue
- 2
- Pages
- 65-72
- ISSN
- 2162-3988 (ISSN-L)
- 2162-3996
- OpenAlex
- W2103667952
- Cited by
- 255
- References
- 79
- FWCI
- 5.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.